Source:http://linkedlifedata.com/resource/pubmed/id/19717386
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-8-31
|
pubmed:abstractText |
Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1938-0712
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
328-30
|
pubmed:meshHeading |
pubmed-meshheading:19717386-Aged, 80 and over,
pubmed-meshheading:19717386-Antineoplastic Agents,
pubmed-meshheading:19717386-Humans,
pubmed-meshheading:19717386-Male,
pubmed-meshheading:19717386-Multiple Myeloma,
pubmed-meshheading:19717386-Plasma Cells,
pubmed-meshheading:19717386-Remission Induction,
pubmed-meshheading:19717386-Thalidomide
|
pubmed:year |
2009
|
pubmed:articleTitle |
Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
|
pubmed:affiliation |
Department of Medicine, Roswell Park Cancer Institute and the State University of New York, Buffalo, NY, USA.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|